摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-BrC6H4CHNCH2CH2NMe2 | 151488-38-9

中文名称
——
中文别名
——
英文名称
2-BrC6H4CHNCH2CH2NMe2
英文别名
2-[(2-bromophenyl)methylideneamino]-N,N-dimethylethanamine
2-BrC6H4CHNCH2CH2NMe2化学式
CAS
151488-38-9
化学式
C11H15BrN2
mdl
——
分子量
255.157
InChiKey
WGEBTMMWCXJBST-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    304.9±27.0 °C(Predicted)
  • 密度:
    1.22±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    15.6
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2-BrC6H4CHNCH2CH2NMe2bis(1,5-cyclooctadiene)nickel (0)草酰氯二甲基亚砜三(邻甲基苯基)磷 作用下, 以 二氯甲烷乙腈 为溶剂, 反应 2.5h, 生成
    参考文献:
    名称:
    Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer
    摘要:
    DOI:
    10.1021/acs.jmedchem.1c00318
  • 作为产物:
    描述:
    N,N-二甲基乙二胺邻溴苯甲醛甲醇 为溶剂, 以100%的产率得到2-BrC6H4CHNCH2CH2NMe2
    参考文献:
    名称:
    Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer
    摘要:
    DOI:
    10.1021/acs.jmedchem.1c00318
点击查看最新优质反应信息

文献信息

  • Oxidative addition of aryl–halogen bonds to platinum(<scp>II</scp>) and the structure of a complex formed by aryl–fluoride oxidative addition
    作者:Craig M. Anderson、Richard J. Puddephatt、George Ferguson、Alan J. Lough
    DOI:10.1039/c39890001297
    日期:——
    The complexes [PtMe2(Me2NCH2CH2NCHAr)] react by oxidative addition of the aryl–halogen bond when Ar = 2-BrC6H4, 2-CIC6H4, or C6F5 but by ortho-metallation when Ar = 2-FC6H4 or C6H5, and in the case where Ar = C6F5, the oxidative addition product adds acetone across the imine bond and the complex formed has been characterized crystallographically as a hydrogen-bonded dimer; the reactivity to oxidative
    当Ar = 2-BrC 6 H 4,2 -CIC 6 H 4或C 6 F 5时,配合物[PtMe 2(Me 2 NCH 2 CH 2 N CHAr)]通过芳基-卤素键的氧化加成反应,但通过Ar = 2-FC 6 H 4或C 6 H 5时,以及Ar = C 6 F 5时,进行邻位属化,氧化加成产物通过亚胺键加成丙酮,形成的络合物在晶体学上被表征为氢键二聚体。与氧化加成反应的反应性可能与C–X键能相关。
  • Preparation of Five-Membered Nickelacycles with Anionic C−N−N‘ Terdentate Ligands. X-ray Crystal Structure of [NiCl{2-(CHNCH<sub>2</sub>CH<sub>2</sub>NMe<sub>2</sub>)-3-ClC<sub>6</sub>H<sub>3</sub>}]
    作者:Rosa M. Ceder、Jaume Granell、Guillermo Muller、Mercè Font-Bardía、Xavier Solans
    DOI:10.1021/om960309k
    日期:1996.10.15
    imines derived from N,N-dimethylethylenediamine, C6RnH5-nCH NCH2CH2NMe2 to [Ni(COD)2]. The molecular structure of [NiCl2-(CHNCH2CH2NMe2)-3-ClC6H3}] has been determined by a single-crystal X-ray crystallographic study. Some ionic compounds [Ni(C−N−N‘)L]BF4 (L = NCMe, heterocyclic amines) were also obtained. The NiC bond of these complexes is inert toward insertion reactions of ethylene or PhC⋮CPh. The action
    五元属环[Ni(C-N-N')X]是通过氧化添加衍生自N,N-二甲基乙二胺,C 6 R n H 5 - n CH NCH 2 CH的邻卤代亚胺制备的2 NMe 2至[Ni(COD)2 ]。通过单晶X射线晶体学研究确定了[NiCl 2-(CH NCH 2 CH 2 NMe 2)-3-ClC 6 H 3 }]的分子结构。一些离子化合物[Ni(C-N'N')L] BF 4(L = NCMe,杂环胺)也被获得。这些配合物的Ni C键对乙烯或PhC⋮CPh的插入反应呈惰性。[Ni(COD)2 ]对二胺C 6 R n H 5 - n CH 2 N(Me)CH 2 CH 2 NMe 2的作用提供了高度不溶的有机镍生物,其通过与芳族胺(L)反应TlBF 4的存在导致离子衍生物[Ni(C- N'N ')L] BF 4。使用CuCl 2稳定有机属Ni(III)化合物因为没有达到氧化剂。配位化合物[NiClBr(N'-N)],其中N-N'=
  • Five- and Seven-Membered Metallacycles in [C,N,N′] and [C,N] Cycloplatinated Compounds
    作者:Raquel Martín、Margarita Crespo、Mercè Font-Bardia、Teresa Calvet
    DOI:10.1021/om800864f
    日期:2009.1.26
    The reactions of cis-[Pt(4-C6H4Me)2(μ-SEt2)]2 with ligands ArCH═NCH2CH2NMe2 (Ar = 4-ClC6H4 (1a); 2-BrC6H4 (1b); 2,6-Cl2C6H3 (1c); C6F5 (1d)) and ArCH═NCH2(4-ClC6H4) (Ar = 4-ClC6H4 (1e); 2-BrC6H4 (1f); 2,6-Cl2C6H3 (1g); C6F5 (1h)) were studied. Several types of compounds were formed including (i) [N,N′] coordination compounds (2a, 2c, 2d), (ii) [C,N,N′] platinum(IV) (3b, 3c), [C,N,N′] platinum(II) (4a)
    的反应中的顺式- [PT(4-C 6 H ^ 4 Me)的2(μ-SET 2)] 2与配体ArCH═NCH 2 CH 2 NME 2(AR = 4-CLC 6 ħ 4(1A); 2- BRC 6 ħ 4(1B); 2,6-CL 2 ç 6 ħ 3(1C),C 6 ˚F 5(1D))和ArCH═NCH 2(4-CLC 6 ħ 4)(AR = 4-CLC 6高4(1e); 2-BrC 6 H 4(1f); 2,6-Cl 2 C 6 H 3(1g);研究了C 6 F 5(1h))。形成了几种类型的化合物,包括(i)[N,N']配位化合物(2a,2c,2d),(ii)[C,N,N'](IV)(3b,3c),[C,具有五元属环的N,N'](II)(4a)和[C,N](II)(4e)环属化合物,以及(iii)[C,N,N'](II) )(5c)和具有七元属环的[C,N](II)(5f,
  • Kinetico-Mechanistic Insight into the Platinum-Mediated C−C Coupling of Fluorinated Arenes
    作者:Teresa Calvet、Margarita Crespo、Mercè Font-Bardia、Kerman Gómez、Gabriel González、Manuel Martínez
    DOI:10.1021/om9004934
    日期:2009.9.14
    PtII-metalated compound [PtBr6-(C6F5)(2-C)C5H3CHNCH2(4′-ClC6H4)SEt2] (2c), which contains a five-membered metallacycle with a biaryl linkage involving a C6F5 group. The derivative compounds [PtBr6-(C6F5)(2-C)C5H3CHNCH2(4′-ClC6H4)L] (L = SMe2 (3c), L = PPh3 (4c)) were also prepared, and compound 4c has also been characterized by XRD. The kinetico-mechanistic study of the formation of compound 2c has also
    化合物的反应顺式- [PT(C 6 ˚F 5)2(组2)2 ]与配体亚胺ArCH═NCH 2 CH 2 NME 2(AR = 2- BRC 6 ħ 4(1A)或2,6- CL 2 ç 6 ħ 3(图1b))在甲苯产生配位化合物的顺式- [PT(C 6 ˚F 5)2(ArCH═ ñ CH 2 CH 2 ñ我2)](2a,2b)含有二齿[N,N']配体。从这一点来看,没有观察到进一步的反应性。化合物2b已经通过单晶XRD表征。在类似条件下,亚胺配体2-BrC 6 H 4 CH = NCH 2(4'-ClC 6 H 4)(1c)生成PT II属化化合物[PTBr 6-(C 6 F 5)(2- C)C 5 H 3 CH N CH 2(4'-ClC 6 H 4)SEt 2 ](2c),其中含有带有C 6 F 5基团的联芳基连接的五元属环。衍生物化合物[PTBr 6-(C 6 F 5)(2- C)C
  • New Insights in the Formation of Five- Versus Seven-Membered Platinacycles: A Kinetico-Mechanistic Study
    作者:Paul V. Bernhardt、Teresa Calvet、Margarita Crespo、Mercè Font-Bardía、Susanna Jansat、Manuel Martínez
    DOI:10.1021/ic3023584
    日期:2013.1.7
    actuation of an unexpected equilibrium between its cis-(X,NMe2) and trans-(X,NMe2) isomers. While the cis-(X,NMe2) isomer produces the 7-membered metallacycle, the trans-(X,NMe2) form leads exclusively to the 5-membered analogue. The isomerization process is dominated by the steric hindrance existing between the Ar–Pt and Ar–Ar′CHN-Pt moieties in the cis-(X,NMe2) isomer that forces a Z conformation of
    PT组成的反应(IV)式的有机属配合物环属[PTXAr 2(中,Ar' CH Ñ CH 2 CH 2 Ñ我2)]从制备和动力学机理的角度研究了通过正式的C–C还原消除/ C–H氧化加成/ Ar–H还原消除顺序生产5和7元PT(II)属环的过程。关键中间体的检测和表征还可以通过仔细选择反应条件(包括时间)来实现,这些条件包括从动力学研究中提取的时间。从收集到的数据,很明显的是,反应性的微调是可能的相对于形成所述备选的5-和7-元环属化配合物(即,[PTX(AR-中,Ar' CH = Ñ CH 2 CH 2 ñ我2)]和[PTX(-Ar ' CH = ñCH 2 CH 2 N Me 2)])。在所有情况下出现的共同还原消除反应以形成非环属[PTX(AR)(AR-型的中间体化合物' CH = Ñ CH 2 CH 2 Ñ我2)],这导致上述的选择性形成通过激活其顺式(X,N Me 2)和反式(X,N
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫